Vericel (VCEL) Cash & Equivalents (2010 - 2026)

Vericel has reported Cash & Equivalents for 15 years, with the latest figure at $125.4 million in Q2 2026.

• Quarterly Cash & Equivalents rose 55.71% year-over-year to $125.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $125.4 million (up 55.71% YoY) and the FY2025 annual result came in at $100.1 million, up 34.32% from the prior year.
• Cash & Equivalents grew to $125.4 million in Q2 2026 per VCEL's latest filing, from $109.3 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $125.4 million in Q2 2026 and troughed at $43.0 million in Q2 2023.
• A 5-year average of $71.8 million and a median of $64.1 million in 2022 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2025: Cash & Equivalents decreased 25.26% in 2022, then surged 87.04% in 2025.
• Over 5 years, Cash & Equivalents stood at $51.1 million in 2022, then jumped by 35.29% to $69.1 million in 2023, then climbed by 7.86% to $74.5 million in 2024, then soared by 34.32% to $100.1 million in 2025, then rose by 25.28% to $125.4 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $125.4 million, $109.3 million, and $100.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.